CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands |
Total |
Cumulative Effect, Period of Adoption, Adjustment |
Ordinary Shares |
Treasury Shares |
Additional Paid-in Capital |
Accumulated Other Comprehensive Loss |
Accumulated Deficit |
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
|
Beginning balance (in shares) at Dec. 31, 2021 |
|
|
157,237,435
|
|
|
|
|
|
Beginning balance at Dec. 31, 2021 |
$ 1,081,618
|
$ (1,545)
|
$ 157,237
|
$ 0
|
$ 1,670,033
|
$ (7,135)
|
$ (738,517)
|
$ (1,545)
|
Beginning balance (in shares) at Dec. 31, 2021 |
|
|
|
0
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
Share-based compensation |
4,963
|
|
|
|
4,963
|
|
|
|
Ordinary shares issued related to founders advisory fees - related party (in shares) |
|
|
5,952,992
|
|
|
|
|
|
Ordinary shares issued related to founders advisory fees - related party |
13,783
|
|
$ 5,954
|
|
7,829
|
|
|
|
Ordinary share issued related to warrants exercised (in shares) |
|
|
44,115
|
|
|
|
|
|
Ordinary share issued related to warrants exercised |
529
|
|
$ 44
|
|
485
|
|
|
|
Net income |
36,963
|
|
|
|
|
|
36,963
|
|
Other comprehensive income (loss) |
126
|
|
|
|
|
126
|
|
|
Ending balance (in shares) at Mar. 31, 2022 |
|
|
163,234,542
|
|
|
|
|
|
Ending balance at Mar. 31, 2022 |
1,136,437
|
|
$ 163,235
|
$ 0
|
1,683,310
|
(7,009)
|
(703,099)
|
|
Ending balance (in shares) at Mar. 31, 2022 |
|
|
|
0
|
|
|
|
|
Beginning balance (in shares) at Dec. 31, 2021 |
|
|
157,237,435
|
|
|
|
|
|
Beginning balance at Dec. 31, 2021 |
1,081,618
|
$ (1,545)
|
$ 157,237
|
$ 0
|
1,670,033
|
(7,135)
|
(738,517)
|
$ (1,545)
|
Beginning balance (in shares) at Dec. 31, 2021 |
|
|
|
0
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
Net income |
45,890
|
|
|
|
|
|
|
|
Ending balance (in shares) at Jun. 30, 2022 |
|
|
163,234,542
|
|
|
|
|
|
Ending balance at Jun. 30, 2022 |
1,127,418
|
|
$ 163,235
|
$ (5,008)
|
1,686,743
|
(23,380)
|
(694,172)
|
|
Ending balance (in shares) at Jun. 30, 2022 |
|
|
|
597,513
|
|
|
|
|
Beginning balance (in shares) at Mar. 31, 2022 |
|
|
163,234,542
|
|
|
|
|
|
Beginning balance at Mar. 31, 2022 |
1,136,437
|
|
$ 163,235
|
$ 0
|
1,683,310
|
(7,009)
|
(703,099)
|
|
Beginning balance (in shares) at Mar. 31, 2022 |
|
|
|
0
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
Share-based compensation |
3,433
|
|
|
|
3,433
|
|
|
|
Ordinary shares repurchased (in shares) |
|
|
|
597,513
|
|
|
|
|
Ordinary shares repurchased |
(5,008)
|
|
|
$ (5,008)
|
|
|
|
|
Net income |
8,927
|
|
|
|
|
|
8,927
|
|
Other comprehensive income (loss) |
(16,371)
|
|
|
|
|
(16,371)
|
|
|
Ending balance (in shares) at Jun. 30, 2022 |
|
|
163,234,542
|
|
|
|
|
|
Ending balance at Jun. 30, 2022 |
$ 1,127,418
|
|
$ 163,235
|
$ (5,008)
|
1,686,743
|
(23,380)
|
(694,172)
|
|
Ending balance (in shares) at Jun. 30, 2022 |
|
|
|
597,513
|
|
|
|
|
Beginning balance (in shares) at Dec. 31, 2022 |
156,797,806
|
|
163,234,542
|
|
|
|
|
|
Beginning balance at Dec. 31, 2022 |
$ 1,138,900
|
|
$ 163,235
|
$ (49,341)
|
1,698,781
|
(25,471)
|
(648,304)
|
|
Beginning balance (in shares) at Dec. 31, 2022 |
6,436,736
|
|
|
6,436,736
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
Share-based compensation |
$ (3,074)
|
|
|
|
(3,074)
|
|
|
|
Ordinary shares issued related to founders advisory fees - related party (in shares) |
|
|
1,831,653
|
|
|
|
|
|
Ordinary shares issued related to founders advisory fees - related party |
0
|
|
$ 1,832
|
|
(1,832)
|
|
|
|
Ordinary shares repurchased (in shares) |
|
|
|
115,570
|
|
|
|
|
Ordinary shares repurchased |
(864)
|
|
|
$ (864)
|
|
|
|
|
Net income |
9,431
|
|
|
|
|
|
9,431
|
|
Other comprehensive income (loss) |
1,593
|
|
|
|
|
1,593
|
|
|
Ending balance (in shares) at Mar. 31, 2023 |
|
|
165,066,195
|
|
|
|
|
|
Ending balance at Mar. 31, 2023 |
$ 1,145,986
|
|
$ 165,067
|
$ (50,205)
|
1,693,875
|
(23,878)
|
(638,873)
|
|
Ending balance (in shares) at Mar. 31, 2023 |
|
|
|
6,552,306
|
|
|
|
|
Beginning balance (in shares) at Dec. 31, 2022 |
156,797,806
|
|
163,234,542
|
|
|
|
|
|
Beginning balance at Dec. 31, 2022 |
$ 1,138,900
|
|
$ 163,235
|
$ (49,341)
|
1,698,781
|
(25,471)
|
(648,304)
|
|
Beginning balance (in shares) at Dec. 31, 2022 |
6,436,736
|
|
|
6,436,736
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
Net income |
$ 61,445
|
|
|
|
|
|
|
|
Ending balance (in shares) at Jun. 30, 2023 |
154,520,833
|
|
165,066,195
|
|
|
|
|
|
Ending balance at Jun. 30, 2023 |
$ 1,175,062
|
|
$ 165,067
|
$ (76,553)
|
1,695,070
|
(21,663)
|
(586,859)
|
|
Ending balance (in shares) at Jun. 30, 2023 |
10,545,362
|
|
|
10,545,362
|
|
|
|
|
Beginning balance (in shares) at Mar. 31, 2023 |
|
|
165,066,195
|
|
|
|
|
|
Beginning balance at Mar. 31, 2023 |
$ 1,145,986
|
|
$ 165,067
|
$ (50,205)
|
1,693,875
|
(23,878)
|
(638,873)
|
|
Beginning balance (in shares) at Mar. 31, 2023 |
|
|
|
6,552,306
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
Share-based compensation |
1,195
|
|
|
|
1,195
|
|
|
|
Ordinary shares repurchased (in shares) |
|
|
|
3,993,056
|
|
|
|
|
Ordinary shares repurchased |
(26,348)
|
|
|
$ (26,348)
|
|
|
|
|
Net income |
52,014
|
|
|
|
|
|
52,014
|
|
Other comprehensive income (loss) |
$ 2,215
|
|
|
|
|
2,215
|
|
|
Ending balance (in shares) at Jun. 30, 2023 |
154,520,833
|
|
165,066,195
|
|
|
|
|
|
Ending balance at Jun. 30, 2023 |
$ 1,175,062
|
|
$ 165,067
|
$ (76,553)
|
$ 1,695,070
|
$ (21,663)
|
$ (586,859)
|
|
Ending balance (in shares) at Jun. 30, 2023 |
10,545,362
|
|
|
10,545,362
|
|
|
|
|